MedPath

Training Mental Habits Study

Not Applicable
Completed
Conditions
Worry
Generalized Anxiety
Interventions
Behavioral: Concreteness Training
Registration Number
NCT03205332
Lead Sponsor
Toronto Metropolitan University
Brief Summary

Generalized Anxiety Disorder (GAD) is a chronic condition whose hallmark feature is excessive and uncontrollable worry (American Psychiatric Association, 2013). Theories of GAD propose that specific cognitive biases are involved in the maintenance and etiology of chronic worry. One cognitive bias that plays a role in worrying is abstract thinking, or the tendency to "verbalize" thoughts and worries in a manner that is vague and lacking in detail. There is evidence that training depressed people to think more concretely improves depressive symptoms and depression-type thinking styles, and reduces emotional reactivity. Given that chronic worry and depression have commonalities (e.g., repetitive thinking styles, difficulties with problem-solving and attentional control, emotion dysregulation), concreteness training may help people who struggle with chronic worry. The main goals of this proof of concept experiment are 1) to test in individuals reporting chronic worry the effects of an active form of concreteness training that involves imagery practice (compared to a no training control condition) on frequency of worrying, problem solving quality, and worry-related processes; 2) to examine the degree to which concreteness training causes improvements in daily worry and negative affect during the 7 days of practice. The study design will provide us with an understanding on a more "macro" level of the potential short-term benefits and will at the same time allow us to see, on a more "micro" level, how training concreteness affects worry and mood on a day-to-day basis during a 7-day period. The findings from this study will inform relevant clinical literature about efficacious methods to reduce chronic worry.

Detailed Description

The main goals of this proof of concept experiment are 1) to test in individuals reporting chronic worry the effects of an active form of concreteness training that involves imagery practice (compared to a no training control condition) on frequency of worrying, problem solving quality, and worry-related processes; 2) to examine the degree to which concreteness training causes improvements in daily worry and negative affect during the 7 days of practice. Participants are recruited from the community via advertisements. Following a telephone screen, participants attend a baseline visit during which they complete the MINI interview. Those who continue to be eligible complete the outcome measures and are randomly assigned to either the experimental condition or the control condition. Participants assigned to the experimental condition receive training in concrete processing and learn how to complete the daily experience sampling diary. Participants assigned to the control condition do not receive training and learn how to complete the daily experience sampling diary. All participants then complete their assigned activities for 7 days. They then return to the lab to complete the outcome measures at post-test, 1 week follow up and 1 month follow up. Participants are then debriefed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
121
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Concreteness TrainingConcreteness TrainingParticipants receive 1 session of training in concrete processing during the pre-intervention visit. They are then asked to engage in 30 minutes of concreteness practice daily, for 7 days.
Primary Outcome Measures
NameTimeMethod
Change in worry as measured by the Penn State Worry Questionnaire - Past Weekthis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Secondary Outcome Measures
NameTimeMethod
Change in negative problem orientation as measured by the Negative Problem Orientation Questionnairethis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in problem solving style as measured by the Social Problem Solving Inventory RevisedAdministered at baseline, at post-test (1 week post baseline), at 1-week follow up and at 1-month follow up
Change in residual working memory capacity as measured by the Random Interval Generation Taskthis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in worry as measured by experience sampling completed during the 7 days between baseline and post testDaily during 7-day intervention period
Change in cognitive avoidance as measured by the Cognitive Avoidance Questionnairethis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in affect as measured by experience sampling completed during the 7 days between baseline and post testDaily during 7-day intervention period
Change in concreteness as measured by experience sampling completed during the 7 days between baseline and post test.Daily during 7-day intervention period
Change in depressive symptoms as measured by the Centre for Epidemiological Studies Depression Scalethis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in quality of problem-solving as measured by The Means-Ends Problem-Solving taskthis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in attentional control as measured by the Attentional Control Scalethis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
- Change in interpretation bias as measured by the Ambiguous/ Unambiguous Situations Diary Extendedthis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up
Change in GAD-Q-IV severitythis measure is administered at baseline, at post-test (1 week post baseline), at 1 week follow up and at 1 month follow up

Trial Locations

Locations (1)

Psychology Research and Training Centre, Ryerson University

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath